The MNIT has had a strong history of success in the field of transplantation through its commitment to research and educational programs. MNIT education programs include educating transplant patients, as well as physicians nationally and internationally who have come to MNIT to learn the latest transplant procedures and techniques. Below is a list of many of the MNIT Milestones and Highlights that have significantly impacted its mission.

  • 1984 – MNIT was established to enhance the science of Transplantation. At the time, Transplantation was a very new surgical procedure.
  • 1985 – MNIT establishes Transplant Program at St. Vincent’s Medical Center. The St. Vincent’s Transplant Program grew to become the 2nd largest transplant center in the United States in 2005. The Drs. Mendez remained Directors of this program for 20 years.
  • 1986 – Pancreas Transplant Program created for Diabetic transplant patients
  • 1970 – 2000 – Over 5,000 transplants performed by Drs. Mendez and the Mendez Transplant Team
  • 2002 – Laproscopic nephrectomy. This new surgical procedure is a minimally invasive donor nephrectomy. This is an effective surgical procedure while minimizing impact on body. MNIT Transplant Team incorporates this new procedure in its transplant protocol. MNIT surgeons were the 1st doctor to perform this procedure in Los Angeles.
  • 2003 – MNIT contracted to conduct 200th clinical research study. A hallmark of MNIT’s history, the clinical research department has worked closely with pharmaceutical companies to develop new and better ways to care for and to treat transplant patients.
  • 2006 – MNIT trains its 30th Transplant Fellow. The MNIT Transplant Fellows Program has trained Transplant Surgeons from around the world in the latest transplant techniques and procedures.
  • 2008 – MNIT One-on-One Renal Disease Education Program is nationally recognized at International Transplant Nursing Society Annual Meeting.
  • 2008 – MNIT holds 1st Worldwide Symposium on Alports Syndrome. MNIT Research brought together the world’s experts on Alports for presentations and exchange of research and ideas that are aimed at controlling and providing remedies for this kidney related disease.
  • 2013 – Viracor-IBT Laboratories acquired the assets associated with the laboratory operations of the NIT. The NIT made the decision to transfer its laboratory operations to Viracor-IBT to perpetuate the mission of its foundation, build on the legacy of its laboratory operations, and to provide testing services to more transplant patients across the U.S.